Bormioli Rocco Pharma, an Italian supplier of glass and plastic packaging, has launched its Delta-molded, type 1 glass vials in North America.
Bormioli Rocco Pharma, an Italian supplier of glass and plastic packaging, has made its Delta-molded, type 1 glass vials available to the North American market. The vials are available in a range of sizes and capabilities for injectables, including biologics, and offer high hydrolytic resistance and internal surface homogeneity to protect against delamination and ensure product stability.
Source: Bormioli Rocco
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Mechanistic Hypothesis of Toxicity: Driving Decision Making in Preclinical Translation
July 16th 2025Mechanistic toxicity hypothesis is essential in guiding decision-making and predicting toxicities during the preclinical stages of drug development. The authors highlight the growing importance of integrating advanced technologies like mass spectrometry imaging into toxicology to enhance preclinical translation, foster innovation in therapeutic development, and ultimately improve drug safety and efficacy.